Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: South Korea Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20092
20111
20121
20131
20142
20153
20167
20174
20185
20191
20201
20213
20223
20234
20244
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting9
Active, not recruiting7
Terminated6
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals6
GlaxoSmithKline5
Akebia Therapeutics4
Bayer4
Kyunghee University Medical Center3
Alexion Pharmaceuticals, Inc.2
Amgen2
Boehringer Ingelheim2
Cara Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic50
Anemia11
Kidney Failure, Chronic9
Glomerulonephritis, IGA7
Kidney Diseases6
Glomerulonephritis5
Renal Insufficiency5
Diabetes Mellitus, Type 24
Hypertension4
Proteinuria4

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.